Truist Securities has reiterated its Buy recommendation on TAT Technologies (NASDAQ:TATT), keeping a price target of $61.00. At the time the target was reported, that figure implied about a 32% upside from the stock's cited market price of $46.12.
The stock has outperformed over the past 12 months, producing a 50.47% return for shareholders. The firm carries a market capitalization of roughly $602 million, based on InvestingPro data cited in coverage.
Truist's reaffirmation followed TAT Technologies' recent investor day, an event that included an on-site tour of the company's Greensboro facility and presentations from management on strategic priorities and operational plans. Truist analyst Michael Ciarmoli emphasized that mergers and acquisitions appear to be a principal strategic focus for the company going forward.
In analyst commentary, Truist projected that future wins for the 131 APU (Auxiliary Power Unit) program are likely to materialize nearer to the end of 2026. Those wins, the firm said, would enable company management to begin addressing what Truist characterizes as a sizable $2.2 billion annual market opportunity.
Truist's internal modelling assigns nearly $12.50 per share in value to the 131 line of business, based on an assumed 2% market penetration by 2027. The firm noted, however, that this valuation component is not currently incorporated into the $61 price target.
Analyst interest in TAT Technologies has increased among other brokerages as well. Benchmark raised its price target for the stock from $53 to $58 while maintaining a Buy rating, following the same investor day where Benchmark described management's growth vision as "ambitious and very doable." Separately, Lake Street Capital Markets initiated coverage of the company with a Buy rating and set a $53 price target; Jaeson Schmidt is the analyst listed as taking over coverage at Lake Street.
These analyst moves - including the Truist reaffirmation, Benchmark's target increase, and Lake Street's initiation - reflect heightened attention to TAT Technologies' strategic direction. The commentary highlights both the potential upside tied to the 131 APU opportunity and the role that M&A activity may play in near-term growth plans.
Summary of key updates:
- Truist reaffirms Buy on TAT Technologies with a $61 price target - implying ~32% upside from $46.12.
- Company posted a 50.47% return over the past year and holds an approximate market cap of $602 million.
- Truist flags M&A as a primary focus and anticipates 131 APU wins likely toward late 2026; values 131 line at nearly $12.50 per share under a 2% penetration assumption by 2027, not included in the $61 target.
- Benchmark raised its target from $53 to $58 and maintained Buy; Lake Street initiated coverage with a Buy and $53 target.
Note: The article presents analyst ratings, price targets, and market commentary as reported.